Skip to main content
SpringerLink
Log in

Dapsone and Retinoids

  • Chapter
Cutaneous Lupus Erythematosus

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 119.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • Allen JG, Bloxham DP (1989) The pharmacology and pharmacokinetics of the retinoids. Pharmacol Ther 40:1–27

    Article  Google Scholar 

  • Brecher AR, Orlow SJ (2003) Oral retinoid therapy for dermatologic conditions in children and adolescents. J Am Acad Dermatol. 49:171–182

    Article  PubMed  Google Scholar 

  • Callen JP (1990) Treatment of cutaneous lesions in patients with lupus erythematosus. Dermatol Clin 8:355–365

    PubMed  Google Scholar 

  • Coburn PR, Shuster S (1982) Dapsone and discoid lupus erythematosus. Br J Dermatol 106:105–106

    PubMed  Google Scholar 

  • Coleman MD (1993) Dapsone: modes of action, toxicity and possible strategies for increasing patient tolerance. Br J Dermatol 129:507–513

    PubMed  Google Scholar 

  • Craven NM, Griffiths CE (1996) Topical retinoids and cutaneous biology. Clin Exp Dermatol 21:1–10

    Article  PubMed  Google Scholar 

  • Duna GF, Cash JM (1995) Treatment of refractory cutaneous lupus erythematosus. Rheum Dis Clin North Am 21:99–115

    PubMed  Google Scholar 

  • Duken CM (1984) Retinoids: a review. J Am Acad Dermatol 11:541–552

    PubMed  Google Scholar 

  • Ellis CN, Krach KJ (2001) Uses and complications of isotretinoin therapy. J Am Acad Dermatol 45:S150–157

    Article  PubMed  Google Scholar 

  • Furner BB (1990a) Treatment of subacute cutaneous lupus erythematosus. Int J Dermatol 29:542–547

    PubMed  Google Scholar 

  • Furner BB (1990b) Subacute cutaneous lupus erythematosus response to isotretinoin. Int J Dermatol 29:587–590

    PubMed  Google Scholar 

  • Grupper C, Berretti B (1984) Lupus erythematosus and etretinate. In: Cunliffe WJ, Miller AJ (eds) Retinoid therapy. MTP, Lancaster, pp 73–82

    Google Scholar 

  • Hall RP, Lawley TJ, Smith HR, Katz SI (1982) Bullous eruption of systemic lupus erythematosus. Ann Intern Med 97:165–170

    PubMed  Google Scholar 

  • Katz SI (1999) Sulfones. In: Freeberg MI, Eisen ZA, Wolff K, Austen FK, Goldsmith AL, Katz IS, Fitzpatrick BT (eds) Dermatology in general medicine, 5th ed. McGraw-Hill, New York, pp 2790–2794

    Google Scholar 

  • Katz HI, Waalen J, Leach EE (1999) Acitretin in psoriasis: an overview of adverse effects. J Am Acad Dermatol 41:S7–S12

    PubMed  Google Scholar 

  • Kuhn A, Richter-Hintz D, Oslislo C, Ruzicka T, Megahed M, Lehmann P (2000) Lupus erythematosus tumidus — a neglected subset of cutaneous lupus erythematosus: report of 40 cases. Arch Dermatol 136:1033–1041

    PubMed  Google Scholar 

  • Lang PG Jr (1979) Sulfones and sulfonamides in dermatology today. J Am Acad Dermatol 1:479–492

    PubMed  Google Scholar 

  • Lindskov R, Reymann F (1986) Dapsone in the treatment of cutaneous lupus erythematosus. Dermatologica 172:214–217

    PubMed  Google Scholar 

  • Lo JS, Berg RE, Tomecki KJ (1989) Treatment of discoid lupus erythematosus. Int J Dermatol 28:497–507

    PubMed  Google Scholar 

  • Lubach D, Wagner G (1984) Erfolgreiche Behandlung eines subakut kutanen Lupus erythematodes mit Etretinat. Aktuel Dermatol 10:142–144

    Google Scholar 

  • Lucek RW, Colburn WA (1989) Clinical pharmacokinetics of the retinoids. Clin Pharmacokinet 10:38–62

    Google Scholar 

  • McCormack LS, Elgart ML, Turner ML (1984) Annular subacute cutaneous lupus erythematosus responsive to dapsone. J Am Acad Dermatol 11:397–401

    PubMed  Google Scholar 

  • Miyachi Y, Niwa Y (1982) Effects of KI, colchicine and dapsone on the generation of PMNL-derived oxygen intermediates. Br J Dermatol 107:209–214

    PubMed  Google Scholar 

  • Mok CC, Lau CS (1996) Dapsone syndrome in cutaneous lupus erythematosus. J Rheumatol 23:766–768

    PubMed  Google Scholar 

  • Mok CC, Lau CS, Wong RW (1998) Toxicities of dapsone in the treatment of cutaneous manifestations of rheumatic diseases. J Rheumatol 25:1246–1247

    PubMed  Google Scholar 

  • Newton RC, Jorizzo JL, Solomon AR Jr, Sanchez RL, Daniels JC, Bell JD, Cavallo T (1986) Mechanism-oriented assessment of isotretinoin in chronic or subacute cutaneous lupus erythematosus. Arch Dermatol 122:170–176

    Article  PubMed  Google Scholar 

  • Orfanos CE, Ehlert R, Gollnick H (1987) The retinoids. A review of their clinical pharmacology and therapeutic use. Drugs 34:459–503

    PubMed  Google Scholar 

  • Orfanos CE, Zouboulis CC, Almond-Roesler B, Geilen CC (1997) Current use and future potential role of retinoids in dermatology. Drugs 53:358–388

    PubMed  Google Scholar 

  • Peck GL, DiGiovanna JJ (1999) Retinoids. In: Freeberg MI, Eisen ZA, Wolff K, Austen FK, Goldsmith AL, Katz IS, Fitzpatrick BT (eds) Dermatology in general medicine. 5th ed. McGraw-Hill, New York, pp 2810–2821

    Google Scholar 

  • Pfeiffer C, Wozel G (2003) Dapsone and sulfones in dermatology: overview and update. J Am Acad Dermatol 48:308–309

    Article  PubMed  Google Scholar 

  • Ruzicka T, Goerz G (1981) Dapsone in the treatment of lupus erythematosus. Br J Dermatol 104:53–56

    PubMed  Google Scholar 

  • Ruzicka T, Wasserman SI, Soter NA, Printz MP (1983) Inhibition of rat mast cell arachidonic acid cyclooxygenase by dapsone. J Allergy Clin Immunol 72:365–370

    Article  PubMed  Google Scholar 

  • Ruzicka T, Meurer M, Braun-Falco O (1985) Treatment of cutaneous lupus erythematosus with etretinate. Acta Derm Venereol 65:324–329

    PubMed  Google Scholar 

  • Ruzicka T, Meurer M, Bieber T (1988) Efficiency of acitretin in the treatment of cutaneous lupus erythematosus. Arch Dermatol 124:897–902

    Article  PubMed  Google Scholar 

  • Ruzicka T, Sommerburg C, Goerz G, Kind P, Mensing H (1992) Treatment of cutaneous lupus erythematosus with acitretin and hydroxychloroquine. Br J Dermatol 127:513–518

    PubMed  Google Scholar 

  • Shornick JK, Formica N, Parke AL (1991) Isotretinoin for refractory lupus erythematosus. J Am Acad Dermatol 24:49–52

    PubMed  Google Scholar 

  • Wiegand UW, Chou RC (1998) Pharmacokinetics of oral isotretinoin. J Am Acad Dermatol 39:S8–12

    PubMed  Google Scholar 

  • Wiegand UW, Chou RC (1998) Pharmacokinetics of acitretin and etretinate. J Am Acad Dermatol 39:S25–33

    PubMed  Google Scholar 

  • Windhorst DB (1982) The use of isotretinoin in disorders of keratinisation. J Am Acad Dermatol 6:708–709

    PubMed  Google Scholar 

  • Wozel G, Barth J (1988) Current aspects of modes of action of dapsone. Int J Dermatol 27:547–552

    PubMed  Google Scholar 

  • Zhu YI, Stiller MJ (2001) Dapsone and sulfones in dermatology: overview and update. J Am Acad Dermatol 45:420–434

    Article  PubMed  Google Scholar 

  • Zuidema J, Hilbers-Modderman ES, Merkus FW (1986) Clinical pharmacokinetics of dapsone. Clin Pharmacokinet 11:299–315

    PubMed  Google Scholar 

Download references

Authors
  1. David Bacman
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Annegret Kuhn
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Thomas Ruzicka
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Hautklinik, Universitätsklinikum Düsseldorf, Moorenstraße 5, 40225, Düsseldorf, Germany

    Annegret Kuhn  & Thomas Ruzicka  & 

  2. HELIOS Klinikum Wuppertal Klinik für Dermatologie, Allergologie und Umweltmedizin, Universitätsklinikum Witten-Herdecke, Arrenbergerstraße 20, 42117, Wuppertal, Germany

    Percy Lehmann

Rights and permissions

Reprints and permissions

Copyright information

© 2005 Springer-Verlag Berlin · Heidelberg

About this chapter

Cite this chapter

Bacman, D., Kuhn, A., Ruzicka, T. (2005). Dapsone and Retinoids. In: Kuhn, A., Lehmann, P., Ruzicka, T. (eds) Cutaneous Lupus Erythematosus. Springer, Berlin, Heidelberg. https://doi.org/10.1007/3-540-26581-3_27

Download citation

  • DOI: https://doi.org/10.1007/3-540-26581-3_27

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-44266-0

  • Online ISBN: 978-3-540-26581-8

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation